Feasibility of circulating tumor DNA testing in hepatocellular carcinoma

BACKGROUND: Advancement of technologies enabling clinical assessment of circulating tumor DNA (ctDNA) are allowing for assessment of tumor specific genetic alterations in patients. This holds incredible promise for early detection of disease, serial monitoring of tumor heterogeneity, elucidation of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Mody, Kabir, Kasi, Pashtoon Murtaza, Yang, Ju Dong, Surapaneni, Phani Keerthi, Ritter, Ashton, Roberts, Ali, Nagy, Rebecca, Borad, Mitesh J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657310/
https://ncbi.nlm.nih.gov/pubmed/31392055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.02.10
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi